Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells is a research paper published in Molecular Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
BLRD VA
Grant: I01 BX003296
BLRD VA
Grant: I01 BX002355
NCI NIH HHS
Grant: R01 CA176846
NCI NIH HHS
Grant: R01 CA178063
NCI NIH HHS
Grant: R03 CA219764
BLRD VA
Grant: I01 BX002703
NCI NIH HHS
Grant: R01 CA216410
National Institutes of Health
Grant: 7I01BX002355-03
Role of Sprouty 2 in Hepatocellular Carcinoma
National Institutes of Health
Grant: 1R03CA219764-01A1
Mechanistic Insight on the Role of Berberine and AMPK in Hepatocellular Carcinoma
National Institutes of Health
Grant: 7R01CA176846-04
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer
National Institutes of Health
Grant: 5R01CA178063-02
Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma
National Institutes of Health
Grant: 5R01CA216410-04
Developing Nano Technology for HER2 Directed Therapy
FWCI
2.30
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals